UNC. US: Researchers at the UNC School of Medicine have found that the blood
platelet protein Rasa3 is critical to the success of the common
anti-platelet drug Plavix, which breaks up blood clots during heart
attacks and other arterial diseases.
The findings could lead to more personalized approaches to controlling
platelet activity during heart attacks and other vascular emergencies
and diseases.